Siegfried locks in CHF 200m bond deal as investors bet big on pharma outsourcing boom

The bonds, due June 15, 2030, were placed with Swiss investors under the joint lead of UBS and Zürcher Kantonalbank

Dr. Reddy’s to participate in HSBC, Bank of America investor conferences

Pharma major to engage with institutional investors through group meetings in Mumbai and Singapore during May 2026

Investors pile in as Cordance secures oversubscribed seed round for brain-cancer tech

The fresh capital will propel Cordance into its first-in-human clinical trial

Yatharth Hospitals names Ashutosh Kumar Jha as Group Chief – Strategy, M&A, and Investor Relations

ENPICOM secures extended financing from current investors

Investment will help fuel international partnerships, grow IGX Platform functionality, and diversify proposition with new generative AI solutions

Pharma companies with ESG more valuable say investors

When asked how to balance ESG with broader business goals, the panel was unanimous in its assessment that ESG is ‘good for business’

Qure.ai raises US $ 40 million from healthcare investors Novo Holdings and HealthQuad

The funding will accelerate the AI-driven healthcare company's market expansion into the global market and support new product development

Hoola Health raises $5 million to expand child-centric paediatric care

Bengaluru-based startup will use the fresh capital to enter new markets, enhance technology capabilities, and scale its integrated care model

Wegovy pill smashes past 3mn prescriptions in under six months in US

The company said Wegovy hit its first one million prescriptions within 12 weeks of availability

ResMed acquires Noctrix Health for $340 million

Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio